Athanasios Vasilopoulos

528 total citations
22 papers, 354 citations indexed

About

Athanasios Vasilopoulos is a scholar working on Pulmonary and Respiratory Medicine, Electrical and Electronic Engineering and Oncology. According to data from OpenAlex, Athanasios Vasilopoulos has authored 22 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Electrical and Electronic Engineering and 6 papers in Oncology. Recurrent topics in Athanasios Vasilopoulos's work include Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and HER2/EGFR in Cancer Research (4 papers). Athanasios Vasilopoulos is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and HER2/EGFR in Cancer Research (4 papers). Athanasios Vasilopoulos collaborates with scholars based in United States, Japan and Israel. Athanasios Vasilopoulos's co-authors include Y. Papananos, G. Theodoratos, Özkan Özden, Dai H. Chung, Eric J. Rellinger, Jingbo Qiao, Seong‐Hoon Park, Ha Yong Song, David Gius and Pritha Paul and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and IEEE Journal of Solid-State Circuits.

In The Last Decade

Athanasios Vasilopoulos

18 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Athanasios Vasilopoulos United States 7 169 115 88 86 68 22 354
Xu He China 9 42 0.2× 46 0.4× 84 1.0× 9 0.1× 10 0.1× 21 289
Guanyu Yang China 7 49 0.3× 9 0.1× 55 0.6× 7 0.1× 2 0.0× 15 233
Miki Japan 7 3 0.0× 125 1.1× 14 0.2× 43 0.5× 32 0.5× 22 338
Pooja Singh India 12 151 0.9× 33 0.3× 8 0.1× 83 1.2× 43 388
K.E. Kwok Canada 15 24 0.1× 11 0.1× 4 0.0× 60 0.7× 233 3.4× 31 400
Peter Åberg Sweden 10 4 0.0× 262 2.3× 2 0.0× 288 3.3× 10 0.1× 24 564
N Moradzadeh United States 3 5 0.0× 17 0.1× 3 0.0× 31 0.4× 9 0.1× 6 341
Jianming Zhu China 10 8 0.0× 60 0.5× 88 1.0× 25 0.4× 23 315
Klaus J. Miescke United States 8 57 0.3× 5 0.0× 98 1.1× 11 0.1× 5 0.1× 24 456
Shengguo Hu China 7 5 0.0× 110 1.0× 3 0.0× 20 0.2× 15 0.2× 11 283

Countries citing papers authored by Athanasios Vasilopoulos

Since Specialization
Citations

This map shows the geographic impact of Athanasios Vasilopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athanasios Vasilopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athanasios Vasilopoulos more than expected).

Fields of papers citing papers by Athanasios Vasilopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athanasios Vasilopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athanasios Vasilopoulos. The network helps show where Athanasios Vasilopoulos may publish in the future.

Co-authorship network of co-authors of Athanasios Vasilopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Athanasios Vasilopoulos. A scholar is included among the top collaborators of Athanasios Vasilopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athanasios Vasilopoulos. Athanasios Vasilopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cecchini, Michael, Manish Sharma, Yasutoshi Kuboki, et al.. (2025). Genomic alterations in circulating tumor DNA (ctDNA) and response to telisotuzumab adizutecan (ABBV-400) treatment in patients (pts) with colorectal cancer (CRC).. Journal of Clinical Oncology. 43(4_suppl). 258–258.
3.
Perets, Ruth, Manish Sharma, John H. Strickler, et al.. (2024). Phase 1b study evaluating the efficacy and safety of ABBV-400, a c-Met–targeting antibody-drug conjugate, in select advanced solid tumor indications.. Journal of Clinical Oncology. 42(16_suppl). TPS3162–TPS3162.
4.
Sharma, Manish, John H. Strickler, David Sommerhalder, et al.. (2024). First-in-human study of ABBV-400, a novel c-Met–targeting antibody-drug conjugate, in advanced solid tumors: Results in colorectal cancer.. Journal of Clinical Oncology. 42(16_suppl). 3515–3515. 9 indexed citations
5.
6.
7.
Bar, Jair, Shobhit Baijal, Weidong Zhao, et al.. (2023). 1397P Prevalence, molecular characterization, and prognosis of MET–overexpressing non-small cell lung cancer (NSCLC) in a real-world patient cohort. Annals of Oncology. 34. S799–S800. 2 indexed citations
8.
Ansell, Peter, D. Ross Camidge, Shobhit Baijal, et al.. (2023). Evaluation of the prevalence of MET and protein tyrosine kinase 7 expression in non-small cell lung cancer to evaluate overlap of ADC antigens.. Journal of Clinical Oncology. 41(16_suppl). e21105–e21105. 1 indexed citations
9.
Büchel, Julian, Abu Sebastian, Benedikt Kersting, et al.. (2023). Gradient descent-based programming of analog in-memory computing cores. 1 indexed citations
10.
Strickler, John H., D. Ross Camidge, Yasutoshi Kuboki, et al.. (2023). 691P Efficacy of ABBV-400 monotherapy in patients with MET gene amplified advanced solid tumors. Annals of Oncology. 34. S482–S482. 3 indexed citations
11.
Shimizu, Toshio, John D. Powderly, Manish Sharma, et al.. (2023). MO4-2 Phase 1 study of ABBV-400, a novel anti-Met antibody drug conjugate, in advanced solid tumors. Annals of Oncology. 34. S1397–S1397. 1 indexed citations
12.
Camidge, D. Ross, Shobhit Baijal, Athanasios Vasilopoulos, et al.. (2023). Impact of genomic alterations measured in circulating tumor DNA (ctDNA) on clinical response to telisotuzumab vedotin treatment in patients with non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 41(16_suppl). 9032–9032. 2 indexed citations
13.
Büchel, Julian, Athanasios Vasilopoulos, Benedikt Kersting, et al.. (2022). Gradient descent-based programming of analog in-memory computing cores. 2022 International Electron Devices Meeting (IEDM). 33.1.1–33.1.4. 10 indexed citations
14.
Vasilopoulos, Athanasios. (2019). Non- Parametric Statistics: A Set of Statistical Techniques to Compare Two or More Independent Populations. Journal of Strategic Innovation and Sustainability. 14(6).
15.
Song, Ha Yong, Eric J. Rellinger, Seong‐Hoon Park, et al.. (2018). Inhibition of Sirtuin 6 Induces Neuroblastoma Differentiation. Anticancer Research. 38(2). 647–654. 14 indexed citations
16.
Vasilopoulos, Athanasios. (2015). The Assignment Problem: Searching for An Optimal and Efficient Solution. 6(1). 1–12. 4 indexed citations
17.
Vasilopoulos, Athanasios, et al.. (2006). A User-friendly Benchmark Tool For MOS Models. DSpace - NTUA (National Technical University of Athens). 147–150.
18.
Papananos, Y., et al.. (2006). A 1-V, 5.5-GHz, CMOS LNA With Multiple Magnetic Feedback. IEEE Transactions on Circuits and Systems II Analog and Digital Signal Processing. 53(9). 971–975. 4 indexed citations
19.
Vasilopoulos, Athanasios, et al.. (2006). A Low-Power Wideband Reconfigurable Integrated Active-RC Filter With 73 dB SFDR. IEEE Journal of Solid-State Circuits. 41(9). 1997–2008. 102 indexed citations
20.
Vasilopoulos, Athanasios, et al.. (1978). Modification of Control Chart Limits in the Presence of Data Correlation. Journal of Quality Technology. 10(1). 20–30. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xu He Breakdown of academic impact, for papers by Guanyu Yang Breakdown of academic impact, for papers by Miki Breakdown of academic impact, for papers by Pooja Singh Breakdown of academic impact, for papers by K.E. Kwok Breakdown of academic impact, for papers by Peter Åberg Breakdown of academic impact, for papers by N Moradzadeh Breakdown of academic impact, for papers by Jianming Zhu Breakdown of academic impact, for papers by Klaus J. Miescke Breakdown of academic impact, for papers by Shengguo Hu
Rankless by CCL
2026